Skip to main content

Horse Chestnut

Scientific Name(s): Aesculus californica Nutt. (California buckeye), Aesculus glabra Willd. (Ohio buckeye), Aesculus hippocastanum L. (horse chestnut), Aesculus turbinata Blume
Common Name(s): Aescin, Aesculaforce, Buckeye, California buckeye, Castanea equine, Chestnut, Escin, Essaven, Horse chestnut, Japanese horse chestnut, Ohio buckeye, Semen hippocastani

Medically reviewed by Drugs.com. Last updated on Nov 22, 2023.

Clinical Overview

Use

Oral horse chestnut seed extract is effective in the short-term treatment of mild to moderate long-term venous insufficiency, but not for post-thrombotic syndrome. Other investigations focus on the role of the major component aescin in male fertility, antiobesity, and anti-inflammatory effects. Aescin gel has been evaluated for use in bruising.

Dosing

Aescin 20 to 120 mg taken orally has been used for venous insufficiency and is available in tablet form. Oral tinctures and topical gels containing aescin 2% are also available.

Contraindications

Renal or hepatic impairment may be relative contraindications to the use of aescin or horse chestnut derivatives.

Pregnancy/Lactation

Avoid use. Information regarding safety and efficacy in pregnancy and lactation is lacking.

Interactions

None well documented.

Adverse Reactions

The most commonly cited adverse effects include nausea and stomach discomfort, which may be minimized by the use of film-coated tablets. Other mild and infrequent complaints include headache, dizziness, and pruritus. Rare cases of allergy and anaphylaxis have been reported. A single case of acute effusive pericarditis that led to cardiac tamponade has been reported.

Toxicology

All parts of plants in the Aesculus family are potentially toxic, especially the seeds (nuts). Horse chestnut has been classified by the Food and Drug Administration (FDA) as an unsafe herb.

Scientific Family

Botany

Members of the genus Aesculus grow as trees and shrubs, often attaining heights of 23 m. The fruit is a capsule with a thick, leathery husk that contains 1 to 6 dark seeds (nuts). As the husk dries, the nuts are released. The pink and white flowers of the plant grow in clusters. The tree is native to the woods of the Balkan region of southeastern Europe and to western Asia, but is now cultivated worldwide. The dried ripe seeds of the plant are of most medicinal interest.Chevallier 1996, USDA 2010, WHO 2004

History

Because of their prevalence, chestnuts have been used in traditional medicine and in a variety of commercial applications for centuries. Extracts of the bark have been used as a yellow dye, and the wood has been used for furniture and packing cases. In the western United States, the crushed, unripe seeds of the California buckeye were scattered into streams to stupefy fish, and leaves were steeped as tea to remedy congestion. The horse chestnut has been used as a traditional remedy for arthritis and rheumatism, as well as for gynecological bleeding and as a tonic.

Even though the seeds are toxic, several traditional methods were employed to rid them of their toxicity. Seeds were buried in swampy, cold ground during the winter to free them of toxic, bitter components, and then eaten in the spring after boiling. American Indians roasted the poisonous nuts, peeled and mashed them, and then leached the meal in lime water for several days, creating a meal used to make bread.Duke 1985, Evans 1989, Tyler 1988, WHO 2004

Chemistry

The seeds of Aesculus contain a variety of complex constituents. The seed oil contains 65% to 70% oleic acid. The seeds contain protein, ash, and 74% carbohydrate, and triterpene oligoglycosides from horse chestnut seeds have been isolated.

The main active constituents isolated from horse chestnut are aescin (10%) and prosapogenin. Aescin (escin) is a mix of the triterpene saponins alpha- and beta-aescin and cryptoaescin.

Bioflavonoids present include quercetin and kaepferol, and their derivatives. Antioxidants, such as proanthocyanidin, and coumarins, including the toxic esculin, as well as fraxin and pavietin, are also found in the Aesculus genus.

Specific assays have been described to quantify the aescin content of preparations, including high-pressure liquid chromatography, thin-layer chromatography, and mass spectroscopy.Curir 2007, Kapusta 2007, Ogawa 2008, Sirtori 2001, WHO 2004

Uses and Pharmacology

Anti-inflammatory

Animal and anti-inflammatory data

Inhibition of cyclooxygenase activity of Japanese horse chestnut seed extract has been demonstrated in animal experiments.(Guillaume 1994, Sato 2006, Sato 2007) Meanwhile, beta-escin has been shown to inhibit NF-kappaB activation in different conditions,(Michelini 2018) including an allergic airway inflammation model.(Salinas 2019) The bark of Aesculus is also reported to possess the anti-inflammatory steroids stigmasterol, alpha-spinasterol, and beta-sitosterol.(Senatore 1989, Tsutsumi 1967) Topical dermal application of escin has also demonstrated significant dose-dependent anti-inflammatory effects in a cutaneous inflammation rat model.(Zhao 2018)

Antiviral activity

Animal and experimental data

In vitro studies have demonstrated a dose-dependent antiviral effect of beta-escin as well as A. hippocastanum seed extract against HSV-1 in human corneal and conjunctival cell lines without cytotoxicity. Inhibition of viral propagation as well as virucidal effects were also reported. However, antiviral effects were observed only for enveloped viruses (ie, VSV, HSV-1, dengue virus type 2) with no inhibition seen when treatment was applied to adenovirus 5.(Michelini 2018) Additionally, in a murine model of pulmonary infection, A. hippocastanum seed extract (but not beta-escin) exhibited antiviral and virucidal activity against respiratory syncytial virus (RSV). A dose-dependent effect was demonstrated in vitro.(Salinas 2019)

Cancer

Animal

Beta-aescin has been evaluated in a number of in vitro studies and animal experiments for antiproliferative, apoptotic, and growth-inhibiting activities.(Niu 2008, Patlolla 2006, Wang 2008) Reductions in the number of aberrant crypt foci, as well as deceased tumor growth, has been demonstrated in rats with induced colon cancer.(Patlolla 2006, Wang 2008) The presence of an acyl group on other chemical constituents of horse chestnut seed extract may be important.(Zhang 2007) Antioxidant and antimutagenic effects have also been described.(Sato 2005) However, an article from one of these research groups has been withdrawn.

Circulation

Animal data

In vitro and animal studies, as well as leg elevation studies, have demonstrated the antiedematous and venotonic effect of the extract. Suggested mechanisms of action include inhibition of the enzymes elastase and hyaluronidase, prevention of leukocyte activation, and influence on capillary filtration.(Pittler 2012, Sirtori 2001, WHO 2004, Wollina 2006) Beta-aescin may have a potential antiedematous role in the management of Bell palsy; however, clinical studies are lacking.(Liu 2008)

Clinical data

Venous insufficiency

Meta-analyses and systematic reviews have consistently concluded that oral horse chestnut seed extract is safe and effective for the short-term treatment (up to 16 weeks) of mild to moderate long-term venous insufficiency.(Pastor-Villaescusa 2015, Pittler 2012, Sirtori 2001, Vogel 2005, Underland 2012) Leg pain was significantly reduced (P < 0.05) in 6 of 7 trials (N = 543) for the extract versus placebo, and in the seventh trial improvement versus baseline was reported.(Pittler 2012) Six trials (n = 502) suggested improved edema in favour of horse chestnut seed extract compared with placebo; while one study found the extract to be as effective as treatment with compression stockings.(Pittler 2012)

Post-thrombotic syndrome

A Cochrane review found 3 studies (up to 2015) of sufficient quality to conduct a meta-analysis on the effect of horse chestnut rutosides for treatment of post-thrombotic syndrome. No statistical significance in the rutoside treated group versus placebo or no treatment, and in comparison with compression stockings was found.(Morling 2015) No studies were found in another Cochrane review for horse chestnut rutosides in the prevention of this syndrome.(Morling 2015)

Other circulation effects

Horse chestnut seed extract has been shown to be effective in reducing symptoms in hemorrhoids (bleeding and swelling), bruising (pain and swelling), and postoperative edema in limited clinical trials.(Reynolds 2006, Sirtori 2001, WHO 2004)

Fertility

Animal data

Varicocele-associated infertility may on part be due to testicular oxidative stress. Animal data suggest escin to demonstrate activity in venous malfunction.(Fang 2010)

Clinical data

A clinical study (n=219) evaluated the effect of 60mg escin daily over 2 months on varicocele-associated infertility. The researchers reported a significant improvement in sperm density, but not motility, compared with surgical intervention and a control group (Vitamin E, pentoxifylline and clomiphene).(Fang 2010)

Obesity

Animal data

Seed extract of Japanese horse chestnut has been evaluated by a limited number of researchers for antiobesity effects. Inhibition of pancreatic lipase in vitro has been demonstrated, leading to suggestions of an antiobesity mechanism of delayed intestinal absorption of dietary fat. Studies have shown the extract to prevent weight gain in high-fat diet mice, as well as decreased adipose tissue content and plasma triglycerol.(Hu 2008, Kimura 2006, Kimura 2008) In one of the animal experiments, blood glucose was reduced following a single dose of extract.(Kimura 2006)

Other uses

In a diabetic wound model in rats, administration of an aqueous-ethanolic extract of horse chestnut significantly improved the rate of wound healing compared to untreated controls (P<0.05). The mechanism appeared to be related to antioxidant effects and induction of enzymes involved in the wound healing process.(Aksoy 2019)

Dosing

Horse chestnut extracts typically are standardized on content of triterpene glycosides, calculated as the major component aescin.

Oral doses of standardized powdered extract 250 to 312.5 mg (equivalent to aescin 100 mg) twice a day have been cited in the Complete German Commission E Monographs.WHO 2004

Oral tinctures and topical gels containing aescin 2% are also available.Suter 2006, WHO 2004

Venous insufficiency

Aescin (oral)

20 or 40 mg 3 times daily (20 mg capsules/tablets taken as 1 to 2 tablets/capsules 3 times daily) or 50 or 75 mg twice daily (1 tablet twice daily).Pittler 2012, Suter 2006

Duration of use for the seed extract in clinical trials has been from 2 to 16 weeks, with steady state being attained after 8 twice-daily dosing intervals.Bassler 2003, Dickson 2004, Fang 2010, Pittler 2012

Postoperative edema

Intravenous aescin (5 to 10 mg) has been used in trials.Sirtori 2001

Pregnancy / Lactation

Horse chestnut seed extract has been used in clinical trials including pregnant women with no apparent ill effects; however, in the absence of specific safety data, use in pregnancy or lactation is not recommended.WHO 2004

Interactions

Because case reports of toxic nephropathy with high-dose aescin exist, horse chestnut extracts should not be coadministered with other nephrotoxic drugs.(WHO 2004)

The coumarin derivatives found in horse chestnut extracts may potentiate warfarin, as well as interfere with highly plasma-bound drugs.(Heck 2000, Scott 2002, Vogel 2005)

The possibility of interference with CYP34A metabolism and P-glycoprotein transport mechanisms of other drugs exists.(Hellum 2008)

Adverse Reactions

Renal or hepatic impairment may be relative contraindications to the use of aescin or horse chestnut derivatives.(Vogel 2005) The issue of renal toxicity is uncertain. Trials conducted in the 1970s suggest aescin from whole horse chestnut extract is not toxic to the renal system; however, caution is still recommended.(Sirtori 2001)

The most commonly cited adverse effects include nausea and stomach discomfort, which may be minimized by the use of film-coated tablets.(Dickson 2004, Leach 2006, Pittler 2012, WHO 2004) Other mild and infrequent complaints include headache, dizziness, and pruritus, although adverse dermatological reactions are rarely reported.(Calapai 2014, Pittler 2012, Sirtori 2001) Rare cases of allergy and anaphylaxis have been reported.(WHO 2004, Sirtori 2001) Consumption of 3 boxes of horse chestnut paste over 1.5 months was suspected as the cause of acute effusive pericarditis that resulted in cardiac tamponade in a 32-year-old previously healthy male.(Edem 2016) A case of small bowel obstruction with multiple perforations that resulted from bezoars after a 61-year-old man consumed a large quantity of chestnuts has also been reported.(Ravindra 2019)

Because hypoglycemic effects have been reported, asecin preparations should be used with caution in persons with diabetes.(Kimura 2006, Vogel 2005, Yoshikawa 1996)

Toxicology

Because Aesculus (horse chestnut) is classified by the FDA as an unsafe herb, all members of this genus should be considered potentially toxic.Duke 1985

Toxic properties have been attributed to a number of components, including glycosides and saponins. Potential toxins identified in the genus include nicotine, quercitin, quercitrin, rutin, saponin, and shikimic acid. The most important toxic principle is esculin. The nut is the most toxic part of the plant. Poisoning is characterized by muscle twitching, weakness, lack of coordination, pupil dilation, vomiting, diarrhea, depression, paralysis, and stupor. Children have been poisoned by drinking tea made from the leaves and twigs, and by eating the seeds; deaths have been reported following such ingestion. Amounts as little as 1% of a child's weight may be poisonous. Gastric lavage and symptomatic treatment have been suggested.Duke 1985, Hardin1974

A 30% ethanol extract of the seed was not mutagenic in the Salmonella test, and a 40% extract was not teratogenic or embryotoxic in rats or rabbits. Decreased birth weight has been observed in rabbits, while sodium aescinate had no effect on the fertility of male rats.WHO 2004 High lead levels are found in horse chestnut plants of Brazilian origin.Caldas 2004

References

Disclaimer

This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.

This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.

Aesculus hippocastanum L. USDA, NRCS. 2010. The PLANTS Database (http://plants.usda.gov, January 2010). National Plant Data Center, Baton Rouge, LA 70874-4490 USA.
Aksoy H, Çevik Ö, Şen A, Göğer F, Şekerler T, Şener A. Effect of horse-chestnut seed extract on matrix metalloproteinase-1 and -9 during diabetic wound healing. J Food Biochem. 2019;43(3):e12758.31353546
Bassler D, Okpanyi S, Schrodter A, Loew D, Schurer M, Schulz HU. Bioavailability of beta-aescin from horse chestnut seed extract: comparative clinical studies of two Galenic formulations. Adv Ther. 2003;20(5):295-304.14964349
Calapai G, Miroddi M, Minciullo PL, et al. Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products - part 1: Achillea millefolium-Curcuma longa. Contact Dermatitis. 2014;71(1):1-12.24621152
Caldas ED, Machado LL. Cadmium, mercury and lead in medicinal herbs in Brazil. Food Chem Toxicol. 2004;42(4):599-603.15019183
Chevallier A. The Encyclopedia of Medicinal Plants. New York, NY: DK Publishing; 1996:159.
Curir P, Galeotti F, Dolci M, Barile E, Lazotti V. Pavietin, a coumarin from Aesculus pavia with antifungal activity. J Nat Prod. 2007;70(10):1668-1671.17914881
Dickson S, Gallagher J, McIntyre L, Suter A, Tan J. An open study to assess the safety and efficacy of Aesculus hippocastanum tablets ( Aesculaforce 50 mg) in the treatment of chronic venous insufficiency. J Herb Pharmacother. 2004;4(2):19-32.15364642
Duke J. Handbook of Medicinal Herbs. Boca Raton, FL: CRC Press; 1985.
Edem E, Kahyaoglu B, Çakar MA. Acute effusive pericarditis due to horse chestnut consumption. Am J Case Rep. 2016;17:305-308.27141926
Evans WC, Brady LR, Robbers JE. Trease and Evans' Pharmacognosy. 13th ed. London, England: Bailliere Tindall; 1989.
Fang Y, Zhao L, Yan F, Xia X, Xu D, Cui X. Escin improves sperm quality in male patients with varicocele-associated infertility. Phytomedicine. 2010:17(3-4):192-196.19682880
Guillaume M, Padioleau F. Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract. Arzneimittleforschung. 1994;44(1):25-35.8135874
Hardin JW, Arena JM. Human Poisoning from Native and Cultivated Plants. 2nd ed. Durham, NC: Duke University Press; 1974.
Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm. 2000;57(13):1221-1227;1228-1230.10902065
Hellum BH, Nilsen OG. In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products. Basic Clin Pharmacol Toxicol. 2008;102(5):466-475.18331390
Hu JN, Zhu XM, Han LK, et al. Anti-obesity effects of escins extracted from the seeds of Aesculus turbinate BLUME (Hippocastanaceae). Chem Pharm Bull (Tokyo). 2008;56(1):12-16.18175967
Kapusta I, Janda B, Szajwaj B, et al. Flavonoids in horse chestnut (Aesculus hippocastanum) seeds and powdered waste water byproducts. J Agric Food Chem. 2007;55(21):8485-8490.17867637
Kimura H, Ogawa S, Jisaka M, Kimura Y, Katsube T, Yokota K. Identification of novel saponins from edible seeds of Japanese horse chestnut (Aesculus turbinata Blume) after treatment with wooden ashes and their nutraceutical activity. J Pharm Biomed Anal. 2006;41(5):1657-1665.16621416
Kimura H, Ogawa S, Katsube T, Jisaka M, Yokota K. Antiobese effects of novel saponins from edible seeds of Japanese horse chestnut (Aesculus turbinata BLUME) after treatment with wood ashes. J Agric Food Chem. 2008;56(12):4783-4788.18512932
Leach MJ, Pincombe J, Foster G. Using horsechestnut seed extract in the treatment of venous leg ulcers: a cost-benefit analysis. Ostomy Wound Manage. 2006;52(4):68-70, 72-74, 76-78.16636364
Liu J, Li Y, Yuan X, Yang Z, Lin Z. Sodium beta-aescin may be an effective therapeutic agent for Bell's palsy. Med Hypotheses. 2008;71(5):762-764.18762387
Michelini FM, Alché LE, Bueno CA. Virucidal, antiviral and immunomodulatory activities of β-escin and Aesculus hippocastanum extract. J Pharm Pharmacol. 2018;70(11):1561-1571.30168142
Morling JR, Yeoh SE, Kolbach DN. Rutosides for prevention of post-thrombotic syndrome. Cochrane Database Syst Rev. 2015;(9):CD005626.26373375
Morling JR, Yeoh SE, Kolbach DN. Rutosides for treatment of post-thrombotic syndrome. Cochrane Database Syst Rev. 2015;(9):CD005625.26376212
Niu YP, Li LD, Wu LM. Beta-aescin: a potent natural inhibitor of proliferation and inducer of apoptosis in human chronic myeloid leukemia K562 cells in vitro. Leuk Lymphoma. 2008;49(7):1384-1391.18452082
Niu YP, Wu LM, Jiang YL, Wang WX, Li LD. Beta-escin, a natural triterpenoid saponin from Chinese horse chestnut seeds, depresses HL-60 human leukaemia cell proliferation and induces apoptosis. J Pharm Pharmacol. 2008;60(9):1213-1220. Retraction in: Jones DS. J Pharm Pharmacol. 2009;61(5):685.18718126
Ogawa S, Kimura H, Niimi A, Katsube T, Jisaka M, Yokota K. Fractionation and structural characterization of polyphenolic antioxidants from seed shells of Japanese horse chestnut ( Aesculus turbinata BLUME). J Agric Food Chem. 2008;56(24):12046-12051.19053354
Pastor-Villaescusa B, Rangel-Huerta OD, Aguilera CM, Gil A. A systematic review of the efficacy of bioactive compounds in cardiovascular disease: carbohydrates, active lipids and nitrogen compounds. Ann Nutr Metab. 2015;66(2-3):168-81.26045206
Patlolla JM, Raju J, Swamy MV, Rao CV. Beta-escin inhibits colonic aberrant crypt foci formation in rats and regulates the cell cycle growth by inducing p21(waf1/cip1) in colon cancer cells. Mol Cancer Ther. 2006;5(6):1459-1466.16818504
Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database Syst Rev. 2012;11:CD003230.23152216
Ravindra RK, Das A, Chew GL, Daniel E. Small bowel obstruction with multiple perforations post chestnut ingestion. BMJ Case Rep. 2019;12(2):bcr-2018-227999.30718266
Reynolds JE, ed. Martindale: The Extra Pharmacopoeia. 31st ed. London, England: Royal Pharmaceutical Society; 1996:1670.
Salinas FM, Vázquez L, Gentilini MV, et al. Aesculus hippocastanum L. seed extract shows virucidal and antiviral activities against respiratory syncytial virus (RSV) and reduces lung inflammation in vivo. Antiviral Res. 2019;164:1-11.30711418
Sato I, Kofujita H, Suzuki T, Kobayashi H, Tsuda S. Antiinflammatory effect of Japanese horse chestnut (Aesculus turbinata) seeds. J Vet Med Sci. 2006;68(5):487-489.16757892
Sato I, Kofujita H, Tsuda S. Identification of COX inhibitors in the hexane extract of Japanese horse chestnut (Aesculus turbinata) seeds. J Vet Med Sci. 2007;69(7):709-712.17675801
Sato I, Suzuki T, Kobayashi H, Tsuda S. Antioxidative and antigenotoxic effects of Japanese horse chestnut (Aesculus turbinata) seeds. J Vet Med Sci. 2005;67(7):731-734.16082125
Scott GN, Elmer GW. Update on natural product—drug interactions. Am J Health Syst Pharm. 2002;59(4):339-347.11885397
Semen hippocastani. In: WHO Monographs on Selected Medicinal Plants. Vol 2. Geneva, Switzerland: World Health Organization; 2004.
Senatore F, Mścisz A, Mrugasiewicz K, Gorecki P. Steroidal constituents and anti-inflammatory activity of the horse chestnut (Aesculus hippocastanum L.) bark. Boll Soc Ital Biol Sper. 1989;65(2):137-141.2751881
Sirtori CR. Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacol Res. 2001;44(3):183-193.11529685
Suter A, Bommer S, Rechner J. Treatment of patients with venous insufficiency with fresh plant horse chestnut seed extract: a review of 5 clinical studies. Adv Ther. 2006;23(1):179-190.16644618
Tsutsumi S, Ishizuka S. Anti-inflammatory effects of the extract of Aesculus hippocastanum L. (horse chesnut) seed [in Japanese]. Shikwa Gakuho. 1967;67(11):1324-1328.5241694
Tyler V. Pharmacognosy. 9th ed. Philadelphia, PA: Lea & Febiger; 1988.
Underland V, Sæterdal I, Nilsen ES. Cochrane summary of findings: horse chestnut seed extract for chronic venous insufficiency. Glob Adv Health Med. 2012;1(1):122-123.24278808
Vogel JH, Bolling SF, Costello RB, et al. Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine). J Am Coll Cardiol. 2005;46(1):184-221.15992662
Wang XH, Xu B, Liu JT, Cui JR. Effect of beta-escin sodium on endothelial cells proliferation, migration and apoptosis. Vascul Pharmacol. 2008;49(4-6):158-165.18718875
Wollina U, Abdel-Naser MB, Mani R. A review of the microcirculation in skin in patients with chronic venous insufficiency: the problem and the evidence available for therapeutic options. Int J Low Extrem Wounds. 2006;5(3):169-180.16928673
Yoshikawa M, Murakami T, Matsuda H, Yamahara J, Murakami N, Kitagawa I. Bioactive saponins and glycosides. III. Horse chestnut. (1): The structures, inhibitory effects on ethanol absorption, and hypoglycemic activity of escins Ia, Ib, IIa, IIb, and IIIa from the seeds of Aesculus hippocastanum L. Chem Pharm Bull (Tokyo). 1996;44(8):1454-1464.8795266
Zhang Z, Li S. Cytotoxic triterpenoid saponins from the fruits of Aesculus pavia L. Phytochemistry. 2007;68(15):2075-2086.17599369
Zhao SQ, Xu SQ, Cheng J, et al. Anti-inflammatory effect of external use of escin on cutaneous inflammation: possible involvement of glucocorticoids receptor. Chin J Nat Med. 2018;16(2):105-112.29455725

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.